Business / Finance

RSS

Mogrify raises additional $16 million to accelerate the development of life-saving cell therapies

Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, today announced the initial close of its Series A funding. The Company raised $16 million USD in this round, bringing the total investment to over $20 million USD to date.

14 Oct 2019

Impress your boss with this course

In this webinar, Dr. Michael W. Dong, Pittcon Short Course Instructor, will review best practices, short cuts, and tricks-of-the-trade to help pharmaceutical and other scientists to become more successful in developing effective HPLC methods (potency and ICH-compliant stability-indicating assays) using method templates and universal generic gradient methods.

From Pittcon 14 Oct 2019

EIB and Univercells sign EUR 20 million loan agreement to advance delivery of vaccines

The European Investment Bank and Univercells S.A have signed a EUR 20 million loan agreement to support the development of a portfolio of four essential and undersupplied vaccines to be delivered at an affordable price.

4 Oct 2019

Alpine HC completes name change to Opera Care

Over the last three years, the Opera range of care beds and pressure care mattresses has evolved to become a core product range for our two key marketplaces; Care Homes, and Care at Home.

From Opera Care 4 Oct 2019

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

3 Oct 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc., an integrated biopharmaceutical company.

From Tanner Pharma Group 29 Aug 2019

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Today, Medigrowth Australia is pleased to provide an update on its activities. Victorian-based Medicinal Cannabis company Medigrowth continues to achieve significant milestones as it navigates a clear path to delivering on its commitment to become a valuable cannabis industry supply chain partner, large scale extraction company and provider of pure, safe and trusted pharmaceutical-grade medical cannabis for delivery to Australian patients.

28 Aug 2019

Enable Injections enters into a development agreement with Genentech

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

21 Aug 2019

Quanterix announces closing of public offering including exercise of underwriters’ option to purchase additional shares

Quanterix announce the closing of its previously announced underwritten public offering of 2,732,673 shares of its common stock.

From Quanterix 13 Aug 2019

Quanterix prices public offering of common stock

Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.

From Quanterix 9 Aug 2019

Quanterix announces proposed public offering of common stock

Quanterix announced that it has commenced an underwritten public offering of $75 million of shares of its common stock.

From Quanterix 7 Aug 2019

Freiburg start-up company takes over publicly traded company ‘CELLINK AB’

The idea of developing a laboratory instrument that handles and sorts individual, viable cells has been realized by researchers in the Laboratory for MEMS Applications in the Department of Microsystems Engineering at the University of Freiburg.

7 Aug 2019

Quanterix corporation releases operating results for second quarter 2019

Quanterix announced financial results for the three and six months ended June 30, 2019.

From Quanterix 6 Aug 2019

Quanterix to release second quarter 2019 financial results and host conference call on Tuesday, August 6, 2019

Quanterix announced that it will release its financial results for second quarter 2019 before the start of trading on Tuesday, Aug. 6, 2019.

From Quanterix 30 Jul 2019

KNAUER celebrates diversity

On May 28, 2019 the “German Diversity Day” took place for the seventh time and on this occasion the Berlin-based laboratory instrument manufacturer KNAUER organized a special campaign for the employees.

From KNAUER Wissenschaftliche Geräte GmbH 30 May 2019

labfolder and cubuslab merge to form Labforward

labfolder GmbH, a leading electronic laboratory notebook provider, and cubuslab GmbH, a leading provider of a manufacturer-independent platform for the digital integration of laboratory instruments, today announced their merger.

23 May 2019

Quanterix announces $50,000 in grants to support promising oncology research

Quanterix announced a call for proposals for a new Accelerator Grant Program.

From Quanterix 16 May 2019

Quanterix corporation releases operating results for first quarter 2019

Quanterix announced financial results for the three months ended March 31, 2019.

From Quanterix 10 May 2019

BioCity invests in high-power analytics platform for swimming and triathlon athletes

BioCity today announced an investment in INCUS Performance, a sports technology start-up that is helping athletes to train better using data.

9 May 2019